marijuana stocks news

Cara Therapeutics to Announce Third Quarter 2016 Financial Results on November 3, 2016

Cara Therapeutics, Inc. (CARA), a biotechnology company focused on developing and commercializing new chemical entities designed to alleviate pain and pruritus by selectively targeting peripheral kappa opioid receptors, today announced that the Company will host a conference call and live audio webcast on Thursday, November 3, 2016, at 4:30 p.m. ET to report third quarter 2016 financial results and provide a corporate update.

To participate in the conference call, please dial 855-445-2816 (domestic) or 484-756-4300 (international) and refer to conference ID 90388150. A live webcast of the call can be accessed under “Events and Presentations” in the News & Investors section of the Company’s website at www.CaraTherapeutics.com.

An archived webcast recording will be available on the Cara website beginning approximately two hours after the call.

About Cara Therapeutics

Cara Therapeutics is a clinical-stage biotechnology company focused on developing and commercializing new chemical entities designed to alleviate pain and pruritus by selectively targeting peripheral kappa opioid receptors. Cara is developing a novel and proprietary class of product candidates that target the body’s peripheral nervous system and have demonstrated initial efficacy in patients with moderate-to-severe pain without inducing many of the undesirable side effects typically associated with currently available pain therapeutics.


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

$SRNA: Q3 Financials and Shareholder Conf. Call

Surna, Inc. Announces Third Quarter Financial Results, Shareholder Conference Call BOULDER, Colorado,…

$TRTC Presentation Now Available for On-Demand Viewing

Terra Tech Corp. Presentation Now Available for On-Demand Viewing Company invites individual…

Beleave Inc. (BLEVF) Announces Initial Cannabis Oil Sales After Receiving Health Canada Authorization

Beleave Announces Initial Cannabis Oil Sales After Receiving Health Canada Authorization Beleave…

Nabis Holdings (NABIF) (NAB) Completes Investments in Two Municipally Approved Provisioning Centres

Nabis Holdings Completes Investments in Two Municipally Approved Provisioning Centres – Muskegon…